Filters: author is AP [Clear All Filters]
- 2004
Population pharmacokinetic modeling of blood-brain barrier transport of synthetic adenosine A1 receptor agonists,
J Pharmacol Exp Ther, vol. 311, no. 3, pp. 1138-46. DOI
- 2003
Characterization of the pharmacokinetics, brain distribution, and therapeutic efficacy of the adenosine A1 receptor partial agonist 2'-deoxy-N6-cyclopentyladenosine in sarin-poisoned rats,
Toxicol Appl Pharmacol, vol. 192, no. 1, pp. 86-94. DOI
Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degree,
Eur J Pharmacol, vol. 481, no. 2-3, pp. 141-6. DOI
Low efficacy adenosine A1 agonists inhibit striatal acetylcholine release in rats improving central selectivity of action,
Neurosci Lett, vol. 343, no. 1, pp. 57-61. DOI
- 2002
Effects of the adenosine A1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release,
Eur J Pharmacol, vol. 454, no. 2-3, pp. 177-82. DOI
Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication,
Arch Toxicol, vol. 76, no. 11, pp. 650-6. DOI
- 1998
Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats,
Br J Pharmacol, vol. 124, no. 3, pp. 607-18. DOI
- 1997
Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats,
Br J Pharmacol, vol. 122, no. 3, pp. 525-33. DOI
Determination of dexmedetomidine in rat plasma by a sensitive [3H]clonidine radioreceptor assay,
J Pharm Sci, vol. 86, no. 7, pp. 822-6. DOI
Time course of action of three adenosine A1 receptor agonists with differing lipophilicity in rats: comparison of pharmacokinetic, haemodynamic and EEG effects,
Naunyn Schmiedebergs Arch Pharmacol, vol. 356, no. 6, pp. 827-37.
- 1996
Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats,
Eur J Pharmacol, vol. 308, no. 3, pp. 311-4. DOI
- 1995
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor,
J Med Chem, vol. 38, no. 20, pp. 4000-6.
Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo,
Br J Pharmacol, vol. 116, no. 3, pp. 1957-64.
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats,
Br J Pharmacol, vol. 114, no. 4, pp. 761-8.
8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor,
Eur J Pharmacol, vol. 290, no. 3, pp. 189-99.
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline,
Br J Pharmacol, vol. 115, no. 7, pp. 1253-9.
- 1994
Partial agonism of theophylline-7-riboside on adenosine receptors,
Naunyn Schmiedebergs Arch Pharmacol, vol. 350, no. 6, pp. 638-45.
Liquid chromatographic determination of the adenosine receptor agonist CGS 21680 in blood using on-line solid-phase extraction on a phenylboronic acid support and fluorescence detection,
J Chromatogr B Biomed Appl, vol. 658, no. 1, pp. 207-12.
- 1993


